Investasi BioNTech diupgrade ke “beli” oleh UBS seiring obat kanker generasi baru kurangi risiko – Investing.com By admin 6 hours ago , Post Content .[#item_full_content] . Sumber : Berita Saham GlobalContinue ReadingPrevious Saham AkzoNobel melonjak 16% setelah tolak tawaran Nippon-Sherwin €73/saham – Investing.comNext Quilla Resources pertimbangkan IPO di Toronto saat proyek Peru dimulai kembali – Investing.comLeave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment *Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ